Woodward Operating Cash Flow decreased by 20.6% to $90.83M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $77.83M to $90.83M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 0.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $98.92M | $146.75M | $39.29M | $10.82M | $35.91M | $107.62M | $5.40M | $34.75M | $115.48M | $152.91M | $46.79M | $97.33M | $153.21M | $141.76M | $34.52M | $77.83M | $125.64M | $233.32M | $114.44M | $90.83M |
| QoQ Change | — | +48.4% | -73.2% | -72.5% | +231.9% | +199.7% | -95.0% | +543.2% | +232.3% | +32.4% | -69.4% | +108.0% | +57.4% | -7.5% | -75.7% | +125.5% | +61.4% | +85.7% | -51.0% | -20.6% |
| YoY Change | — | — | — | — | -63.7% | -26.7% | -86.3% | +221.2% | +221.6% | +42.1% | +766.1% | +180.1% | +32.7% | -7.3% | -26.2% | -20.0% | -18.0% | +64.6% | +231.5% | +16.7% |